We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+4.32%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$690M
AUM Growth
+$20M
Cap. Flow
-$5.92M
Cap. Flow %
-0.86%
Top 10 Hldgs %
18.32%
Holding
349
New
73
Increased
57
Reduced
129
Closed
89

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$12.4M
2
HSY icon
Hershey
HSY
+$8.96M
3
HST icon
Host Hotels & Resorts
HST
+$8.58M
4
TPR icon
Tapestry
TPR
+$6.04M
5
COTY icon
Coty
COTY
+$5.69M

Top Sells

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$9.7M
2
GM icon
General Motors
GM
+$6.74M
3
WHR icon
Whirlpool
WHR
+$6.34M
4
CI icon
Cigna
CI
+$4.77M
5
JPM icon
JPMorgan Chase
JPM
+$4.71M

Sector Composition

Rank Sector Weight
1 Healthcare 14.65%
2 Financials 14.42%
3 Technology 14.14%
4 Consumer Discretionary 12.17%
5 Industrials 11.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SALE
251
DELISTED
RetailMeNot, Inc. Series 1
SALE
$178K 0.03%
17,992
-8,568
-32% -$86.6K
VSTM icon
252
Verastem
VSTM
$578M
$171K 0.02%
10,714
-54
-0.5% -$870
SPNE
253
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$171K 0.02%
16,956
-81
-0.5% -$837
TBHC
254
DELISTED
The Brand House Collective
TBHC
$168K 0.02%
+13,825
New +$193K
CSLT
255
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$156K 0.02%
37,539
-165
-0.4% -$674
KPTI icon
256
Karyopharm Therapeutics
KPTI
$44.6M
$154K 0.02%
1,055
-1,109
-51% -$133K
ECYT
257
DELISTED
Endocyte, Inc. Common Stock
ECYT
$127K 0.02%
41,007
-192
-0.5% -$598
ALPN
258
DELISTED
Alpine Immune Sciences Inc
ALPN
$110K 0.02%
3,391
-17
-0.5% -$414
GNRT
259
DELISTED
Gener8 Maritime, Inc.
GNRT
$96K 0.01%
18,760
-79
-0.4% -$426
FCSC
260
DELISTED
Fibrocell Science Inc.
FCSC
$31K ﹤0.01%
2,872
-14
-0.5% -$208
ADTN icon
261
Adtran
ADTN
$644M
– –
-55,753
Closed -$1.04M
AIG icon
262
American International
AIG
$40.7B
– –
-54,588
Closed -$2.89M
AIZ icon
263
Assurant
AIZ
$14.2B
– –
-16,267
Closed -$1.4M
AJG icon
264
Arthur J. Gallagher & Co
AJG
$64.4B
– –
-40,892
Closed -$1.95M
AMAT icon
265
Applied Materials
AMAT
$419B
– –
-12,169
Closed -$292K
AMGN icon
266
Amgen
AMGN
$224B
– –
-3,717
Closed -$566K
AMZN icon
267
Amazon
AMZN
$2.99T
– –
-9,460
Closed -$338K
ARMK icon
268
Aramark
ARMK
$14.6B
– –
-88,442
Closed -$2.13M
BOX icon
269
Box
BOX
$4.68B
– –
-65,395
Closed -$676K
CAR icon
270
Avis
CAR
$4.96B
– –
-42,382
Closed -$1.37M
CI icon
271
Cigna
CI
$73.6B
– –
-37,266
Closed -$4.77M
CMI icon
272
Cummins
CMI
$87.9B
– –
-13,262
Closed -$1.49M
COF icon
273
Capital One
COF
$134B
– –
-59,284
Closed -$3.77M
CTRN icon
274
Citi Trends
CTRN
$626M
– –
-13,058
Closed -$203K
CVX icon
275
Chevron
CVX
$381B
– –
-5,663
Closed -$594K
9 10
11
12 13

Similar funds

HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $152M AUM 20.08% 1-Year Est. Return
FHC
Forest Hill Capital Little Rock, Arkansas $152M AUM 64.38% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return

Stoneridge Investment Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Stoneridge Investment Partners held 349 positions worth $690M, up 3% from $670M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Stoneridge Investment Partners's Q3 2016 filing shows 73 new, 57 increased, 129 reduced and 89 closed positions. Its largest new stake was Bristol-Myers Squibb: 193,005 shares worth $10.4M. The largest sale was St Jude Medical, an estimated $9.7M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Financials and Technology.

  • Stoneridge Investment Partners's largest Q3 2016 buy was Bristol-Myers Squibb: 193,005 shares worth $10.4M.
  • Stoneridge Investment Partners added most to Philip Morris in Q3 2016, an estimated $5.27M increase.
  • Stoneridge Investment Partners's biggest Q3 2016 reduction was St Jude Medical, cutting an estimated $9.7M.
  • Stoneridge Investment Partners fully exited Cigna in Q3 2016, selling an estimated $4.77M.
  • Stoneridge Investment Partners's ten largest holdings make up 18% of its $690M portfolio in Q3 2016.
  • Stoneridge Investment Partners opened 73 new positions and closed 89 in Q3 2016.
  • Stoneridge Investment Partners's portfolio value rose 3% quarter-over-quarter to $690M.

Based on Stoneridge Investment Partners's 13F filing for Q3 2016, filed 28 Oct 2016.